Estipharm is shaking off the previous trading day's decline and staging an intraday rebound in the 4% range, putting the recovery to the price level seen before the sharp drop on the 20th within reach.

As of 10:41 AM on the 27th, Estipharm is trading at 122,400 won, up 5,700 won from the previous trading day. The gain stands at 4.88%, with a trading volume of 59,491 shares. The stock is maintaining its upward trend, trading above the previous day's closing price of 117,000 won.

The intraday ask price is formed above 122,500 won, while the bid price is set below 122,400 won. Looking at the order book layout, sell orders are distributed in the 123,000 won to 123,700 won range, suggesting that whether the sell walls around 123,000 won are absorbed will determine the extent of further gains.

■ Recovery Process Underway Following Sharp Decline

The recent daily trajectory more closely resembles a recovery path following a sharp drop rather than a sustained uptrend. Estipharm fell 8.05% on the 20th, closing at 114,300 won. It then held flat at 113,900 won on the 21st before slipping to 112,300 won, down 1.49%, on the 22nd. On the 23rd, it rebounded 4.34% to 117,900 won, but closed at 117,000 won on the 24th, down 0.76%.

Today, the stock is once again rising more than 4%, attempting a rebound that exceeds the previous trading day's decline. The current price is only 400 won below the 122,800 won recorded on the 16th, meaning it has essentially recovered the price level it departed from during the June 20 plunge.

However, since this is an intraday figure, further confirmation is needed on whether the current level will be maintained through the close.

[This article is based on intraday market prices and does not recommend buying or selling any specific stock. Stock prices may fluctuate further during the session, and investment decisions and responsibilities rest solely with the investor. This article was written with AI assistance.]